Our Health Library information does not replace the advice of a doctor. Please be advised that this information is made available to assist our patients to learn more about their health. Our providers may not see and/or treat all topics found herein.

Catheter Ablation for a Fast Heart Rate

Treatment Overview

Catheter ablation is a procedure used to selectively destroy areas of the heart that are causing a heart rhythm problem.

Thin, flexible tubes called catheters are inserted into a vein, typically in the groin or neck. They are threaded up through the vein and into the heart. There is an electrode at the tip of each catheter. The electrode sends out radio waves that create heat. This heat destroys the heart tissue that causes the fast heart rate. Another option is to use freezing cold to destroy the heart tissue.

Catheter ablation is done in a hospital where the person can be carefully monitored. The procedure is done with an electrophysiology (EP) study, which can identify specific areas of heart tissue where the fast heart rate may start or where abnormal electrical pathways are located inside or outside the atrioventricular (AV) node. This allows doctors to pinpoint exactly what tiny area of heart muscle to destroy.

A local anesthetic is used at the site where the catheter is inserted. The person may be awake during the procedure but may be sedated or asleep.

What To Expect

You may stay in the hospital overnight. You may have swelling, bruising, or a small lump around the site where the catheters went into your body. You can do light activities at home. Don't do anything strenuous until your doctor says it is okay. This may be for several days.

Why It Is Done

Catheter ablation is used for people who have persistent or recurrent fast heart rates.footnote 1, footnote 2, footnote 3

Ablation might be done to treat:

  • Supraventricular tachycardia (SVT).
  • Wolff-Parkinson-White (WPW) syndrome.
  • Ventricular tachycardia.

Catheter ablation might be done to prevent episodes, relieve symptoms, or prevent future problems. You can decide with your doctor if the benefits of ablation outweigh the possible risks of the procedure.

How Well It Works

Catheter ablation can eliminate atrioventricular nodal reciprocating tachycardia (AVNRT), a type of supraventricular tachycardia, in almost all cases.footnote 4

This procedure can successfully eliminate WPW most of the time. There is a small risk of the arrhythmia recurring even after successful ablation of WPW. But a second session of catheter ablation is usually successful.footnote 4

For ventricular tachycardia, catheter ablation might make the arrhythmia happen less often or stop the arrhythmia from happening again.footnote 5

Risks

Problems during and after catheter ablation are not common. But the procedure has some risks. They include:

Some risks are more likely with certain types of supraventricular tachycardia (SVT). Your doctor can help you know your risk. You will have to decide whether the possible benefits of ablation outweigh these risks. Your doctor can help you decide.

References

Citations

  1. Al-Khatib SM, et al. (2017). 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation, published online October 30, 2017. DOI: 10.1161/CIR.0000000000000549. Accessed November 6, 2017.
  2. Page RL, et al. (2015). 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. DOI: 10.1161/CIR.0000000000000311. Accessed September 23, 2015.
  3. Cronin EM, et al. (2020). 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Journal of International Cardiac Electrophysiology, 59(1): 145–298. DOI: 10.1007/s10840-019-00663-3. Accessed June 28, 2021.
  4. Page RL, et al. (2015). 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. DOI: 10.1161/CIR.0000000000000311. Accessed September 23, 2015.
  5. Al-Khatib SM, et al. (2017). 2017 AHA/ACC/HRS guideline for management of patients with ventricular tachycardias and the prevention of sudden cardiac death. Circulation, published online October 30, 2017. DOI: 10.1161/CIR.0000000000000549. Accessed November 6, 2017.
  6. Brugada J, et al. (2020). 2019 ESC guidelines for the management of patients with supraventricular tachycardia. European Heart Journal, 41(5): 655–720. DOI: 10.1093/eurheartj/ehz467. Accessed December 1, 2021.

Credits

Current as of: July 31, 2024

Author: Ignite Healthwise, LLC Staff
Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

Current as of: July 31, 2024

Author: Ignite Healthwise, LLC Staff

Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

Dear patient

I am excited to announce that I will be relocating my practice to Houston Methodist DeBakey Cardiology Associates. Starting November 4, 2024, my new address will be:

Houston Methodist DeBakey Cardiology Associates
6550 Fannin St.
Smith Tower, Suite 1901
Houston, TX 77030

Please note that my phone number and fax number will also change to the following:
24-Hour Telephone: 713-441-1100
Fax: 713-790-2643
Clinical Support Telephone (M-F, 8-5): 713-441-3515

I am excited about caring for you in my new office and hope you will make the transition with me. I will also continue to refill your medications as I have in the past. To assist, please provide your pharmacy with my new contact information.

Please consider checking your prescription refills to verify that you have enough medication on hand to last you until your next visit. Please note that your medical records will remain at my former office until you authorize their transfer. If you choose for me to continue providing your medical care, please complete and sign the enclosed “Authorization for Release of Medical Records” form and fax it to 713-790-2643. Once we receive your authorization, we will be happy to process the request for you.

Thank you for entrusting me with your medical care. My new team and I are dedicated to making this transition as seamless as possible. For help scheduling an appointment and transitioning your care, please call my new office number above.

I look forward to continuing your care at my new location.

Sincerely,
Gopi A. Shah, MD

Dear patient

Dr. Albert Raizner, Dr. Michael Raizner, and Dr. Mohamed El-Beheary are excited to announce that our practice, Interventional Cardiology Associates, will merge with Houston Cardiovascular Associates on November 1, 2024.

Our new offices are similarly located in Houston, near the Texas Medical Center and in Sugar Land. Our in-hospital care will continue at Houston Methodist Hospital in the Texas Medical Center and Houston Methodist Sugar Land Hospital. Importantly, our new offices expand our services with state-of-the-art equipment and amenities. Our core values will always be, as they began over 40 years ago when Dr. Albert Raizner founded ICA:

Integrity – Compassion – Accountability

Our new address and contact information are:

Your medical records are confidential and remain available at our new locations. We consider it a privilege to serve as your cardiologists and look forward to your continuing with us. However, should you desire to transfer to another physician, you may request a copy of your records by contacting us at our new addresses and phone numbers listed above.

We thank you for your trust and loyalty. As always, we will continue to be here to take care of you. Please do not hesitate to contact us if you have any questions or concerns.

Sincerely,

Dr. Albert Raizner,
Dr. Michael Raizner,
Dr. Mohamed El-Beheary